Federal regulators recently confirmed that Dec. 4 remains the deadline for public comment on the proposed rule that the federal Food and Drug Administration (FDA) would use to regulate laboratory developed tests (LDTs). This was confirmed during a public webinar for the lab and in vitro diagnostics (IVD) industry conducted by the FDA’s Center for […]
To access this post, you must purchase The Dark Report.